Annual Total Expenses
$287.76 M
+$59.58 M+26.11%
December 31, 2023
Summary
- As of February 20, 2025, CSTL annual total expenses is $287.76 million, with the most recent change of +$59.58 million (+26.11%) on December 31, 2023.
- During the last 3 years, CSTL annual total expenses has risen by +$218.57 million (+315.90%).
- CSTL annual total expenses is now at all-time high.
Performance
CSTL Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$80.70 M
-$1.29 M-1.57%
September 30, 2024
Summary
- As of February 20, 2025, CSTL quarterly total expenses is $80.70 million, with the most recent change of -$1.29 million (-1.57%) on September 30, 2024.
- Over the past year, CSTL quarterly total expenses has increased by +$8.93 million (+12.43%).
- CSTL quarterly total expenses is now -1.57% below its all-time high of $81.99 million, reached on June 30, 2024.
Performance
CSTL Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
CSTL Total Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +26.1% | +12.4% |
3 y3 years | +315.9% | +12.4% |
5 y5 years | +980.9% | +12.4% |
CSTL Total Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +114.5% | -1.6% | +100.7% |
5 y | 5-year | at high | +546.1% | -1.6% | +504.1% |
alltime | all time | at high | +1067.2% | -1.6% | +1129.6% |
Castle Biosciences Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $80.70 M(-1.6%) |
Jun 2024 | - | $81.99 M(+4.5%) |
Mar 2024 | - | $78.44 M(+9.3%) |
Dec 2023 | $287.76 M(+26.1%) | $71.78 M(+0.9%) |
Sep 2023 | - | $71.13 M(-0.2%) |
Jun 2023 | - | $71.30 M(-3.1%) |
Mar 2023 | - | $73.56 M(+19.7%) |
Dec 2022 | $228.18 M(+70.1%) | $61.47 M(+4.7%) |
Sep 2022 | - | $58.70 M(-0.9%) |
Jun 2022 | - | $59.21 M(+21.3%) |
Mar 2022 | - | $48.81 M(+21.4%) |
Dec 2021 | $134.16 M | $40.21 M(+13.9%) |
Sep 2021 | - | $35.29 M(+11.8%) |
Jun 2021 | - | $31.57 M(+16.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $27.10 M(+33.3%) |
Dec 2020 | $69.19 M(+55.4%) | $20.33 M(+6.3%) |
Sep 2020 | - | $19.12 M(+43.1%) |
Jun 2020 | - | $13.36 M(-18.4%) |
Mar 2020 | - | $16.38 M(+9.1%) |
Dec 2019 | $44.54 M(+67.3%) | $15.02 M(+45.2%) |
Sep 2019 | - | $10.35 M(+2.1%) |
Jun 2019 | - | $10.13 M(+12.1%) |
Mar 2019 | - | $9.04 M(+35.5%) |
Dec 2018 | $26.62 M(+8.0%) | $6.67 M(+1.6%) |
Sep 2018 | - | $6.56 M(-1.2%) |
Jun 2018 | - | $6.65 M(-1.4%) |
Mar 2018 | - | $6.74 M |
Dec 2017 | $24.65 M | - |
FAQ
- What is Castle Biosciences annual total expenses?
- What is the all time high annual total expenses for Castle Biosciences?
- What is Castle Biosciences annual total expenses year-on-year change?
- What is Castle Biosciences quarterly total expenses?
- What is the all time high quarterly total expenses for Castle Biosciences?
- What is Castle Biosciences quarterly total expenses year-on-year change?
What is Castle Biosciences annual total expenses?
The current annual total expenses of CSTL is $287.76 M
What is the all time high annual total expenses for Castle Biosciences?
Castle Biosciences all-time high annual total expenses is $287.76 M
What is Castle Biosciences annual total expenses year-on-year change?
Over the past year, CSTL annual total expenses has changed by +$59.58 M (+26.11%)
What is Castle Biosciences quarterly total expenses?
The current quarterly total expenses of CSTL is $80.70 M
What is the all time high quarterly total expenses for Castle Biosciences?
Castle Biosciences all-time high quarterly total expenses is $81.99 M
What is Castle Biosciences quarterly total expenses year-on-year change?
Over the past year, CSTL quarterly total expenses has changed by +$8.93 M (+12.43%)